Idiopathic Thrombocytopenic Purpura in Patients with Ischaemic Heart Disease - A Therapeutic Challenge

  • AKM Monwarul Islam Associate Professor, Department of Cardiology, National Institute of Cardiovascular Diseases, Dhaka
  • Tanveer Ahmed Specialist, Department of Cardiology, United Hospital Ltd., Dhaka
  • Ishrat Jahan Shimu Assistant Registrar, Department of Cardiology, National Institute of Cardiovascular Diseases, Dhaka
  • Samsun Nahar Specialist, Department of Cardiology, United Hospital Ltd., Dhaka
  • Mohammad Arifur Rahman Junior Consultant, Department of Cardiology, National Institute of Cardiovascular Diseases, Dhaka
  • Afzalur Rahman Afzalur Rahman, Director and Professor, National Institute of Cardiovascular Diseases, Dhaka
Keywords: Idiopathic Thrombocytopenic Purpura, Coronary Artery Disease, Thrombocytopenia

Abstract

Idiopathic thrombocytopenic purpura (ITP) and myocardial infarction (MI) in an individual patient is a rare combination. MI mandates thrombolytic and antiplatelet therapy which increases the risk of bleeding in ITP. So far, no guideline deals with management protocol for ischaemic heart disease (IHD) in ITP patients. Here, we describe 2 cases of IHD who developed ITP while on antiplatelet therapy.

Bangladesh Heart Journal 2018; 33(1) : 74-77

Downloads

Download data is not yet available.
Abstract
463
PDF
367

Author Biography

AKM Monwarul Islam, Associate Professor, Department of Cardiology, National Institute of Cardiovascular Diseases, Dhaka


Published
2018-07-03
How to Cite
Islam, A., Ahmed, T., Shimu, I., Nahar, S., Rahman, M. A., & Rahman, A. (2018). Idiopathic Thrombocytopenic Purpura in Patients with Ischaemic Heart Disease - A Therapeutic Challenge. Bangladesh Heart Journal, 33(1), 74-77. https://doi.org/10.3329/bhj.v33i1.37029
Section
Case Reports